Related Experiment Videos
HIV transmission through donor artificial insemination
M R Araneta1, L Mascola, A Eller
1Los Angeles County Department of Health Services, CA.
JAMA
|March 15, 1995
Summary
Donor artificial insemination (AI) before 1986 posed a risk of human immunodeficiency virus (HIV) transmission. Seven percent of women receiving AI from infected donors tested HIV-positive, highlighting the need for retrospective screening and patient inquiry.
Area of Science:
- Reproductive Medicine
- Infectious Disease Epidemiology
- Public Health
Background:
- Donor insemination practices before widespread human immunodeficiency virus (HIV) screening posed risks.
- The potential for HIV transmission through artificial insemination (AI) using infected donor sperm was a significant public health concern prior to 1986.
Purpose of the Study:
- To investigate and document instances of HIV transmission via donor artificial insemination (AI) conducted before the implementation of routine HIV screening for semen donors.
- To assess the prevalence of HIV infection among women who underwent AI procedures using semen from identified HIV-positive donors.
Main Methods:
- Conducted retrospective look-back studies at five infertility clinics.
- Identified HIV-infected women with prior AI history to trace donors and their recipients.
- Examined women who received AI from identified HIV-infected donors.
Main Results:
- Seven of 199 women (3.52%) who consented to testing were HIV-seropositive after receiving AI from one of five identified HIV-infected donors.
- Three of the five donors with available risk information reported a history of sex with men.
- Four HIV-infected women were identified through circumstances unrelated to routine donor screening.
Conclusions:
- HIV transmission through donor AI before 1986 presented a serious risk to recipients.
- Recommended public health policies include retrospective identification of infected donors and AI recipients, particularly in AIDS-prevalent regions.
- Advised questioning women diagnosed with HIV or AIDS without an identified risk factor about prior AI procedures.